Stakeholders welcome FDA’s informed consent ‘key information’ guidance
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsEthicsGenericsMedical DevicesPharmaceuticalsUnited StatesRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsEthicsGenericsMedical DevicesPharmaceuticalsUnited States